2RY Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - China SXT Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 1.97 EUR -13.6%

Market Cap: €27.9m

	China SXT Pharmaceuticals Inc F:2RY	CN
	Stadler Rail AG F:6RL	CH
	BioCardia Inc F:6JU	US
R	Rafhan Maize Products Co Ltd KAR:RMPL	PK
F	Fremont Gold Ltd OTC:FRERF	CA
T	TECOM Co Ltd TWSE:2321	TW
	First Bitcoin Capital Corp OTC:BITCF	CA
S	Synlogic Inc F:MINA	US
S	Scandinavian Real Heart AB F:782	SE
I	Intouch Holdings PCL SET:INTUCH	TH
	Spectra7 Microsystems Inc F:7M0A	CA
	Zabka Group SA F:9M1	LU
S	SCI Electric PCL SET:SCI	TH
	Metals One PLC OTC:MTOPF	UK
C	Charan Insurance PCL SET:CHARAN	TH
A	Avanceon Ltd KAR:AVN	PK

Profitability Summary

China SXT Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

22%

Sustainable 3Y Average Gross Margin

25%

Gross Margin is Increasing

22% > 22%

Negative Operating Margin

-626%

Negative 3Y Average Operating Margin

-308%

Declining Operating Margin

-267% > -626%

Negative Net Margin

-545%

Negative 3Y Average Net Margin

-331%

Declining Net Margin

-301% > -545%

Negative Free Cash Flow Margin

-463%

Negative 3Y Average Free Cash Flow Margin

-172%

Declining Free Cash Flow Margin

-8% > -463%

Negative ROE

-27%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-61%

Declining ROIC

-38% > -168%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.